New Route to Paricalcitol

  • ChemPubSoc Europe Logo
  • Author: Asian Journal of Organic Chemistry
  • Published Date: 26 August 2014
  • Source / Publisher: Asian Journal of Organic Chemistry/Wiley-VCH
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
thumbnail image: New Route to Paricalcitol

Paricalcitol, an A-ring-modified 19-nor analogue of 1α,25-dihydroxyvitamin D2, is currently used for the treatment and prevention of secondary hyperparathyroidism associated with chronic renal failure. 

Kazuo Nagasawa and co-workers, Tokyo University of Agriculture and Technology, Japan, have developed a novel synthetic method for producing the A-ring synthons for paricalcitol. The synthesis is based on ring-closing olefin metathesis of a linear precursor, followed by palladium-catalyzed isomerization of the endocyclc olefin product to give exocyclic olefin. The resulting A-ring synthons were successfully applied to the synthesis of paricalcitol.

The key feature of this method is that it is flexible enough for the modification of A-ring synthons, which means that a variety of novel paricalcitol analogues modified at the A-ring should be easy to produce. Structural developments of paricalcitol based on this synthesis are currently being studied.

Article Views: 2982

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from, please contact us first for permission. more

CONNECT: on Facebook on Twitter on YouTube on LinkedIn Sign up for our free newsletter

A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH